Literature DB >> 7855188

Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice.

R J Rodgers1, J K Shepherd.   

Abstract

A single prior undrugged exposure to the elevated plus-maze has been reported to reduce open arm activity on retest and to attenuate/abolish the anxiolytic response to benzodiazepines at retest intervals ranging from 48 h to 14 days. The present study was designed to examine the generality of these findings by comparing the effects of prior maze experience on baseline behaviour and response to diazepam in two murine models of anxiety. Parallel experiments were conducted in which DBA/2 mice were exposed/not exposed to the plus-maze, treated daily with saline or diazepam (2-4 mg/kg daily for 8 days) and then tested on either the elevated plus-maze or in the light/dark test of exploration. Results show that, in both tests, diazepam reduced behavioural indices of anxiety in maze-naive mice only. However, interpretation of this apparent loss of diazepam efficacy is at least partially confounded by the observation that maze experience per se altered baseline behaviour in both procedures, reducing open arm activity in the plus-maze and increasing light compartment activity in the light/dark test. The apparent elimination of an anxiolytic response to diazepam in two animal models of anxiety by prior plus-maze experience is discussed in relation to experience-related baseline shifts in behaviour.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7855188     DOI: 10.1007/bf02245704

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  25 in total

1.  Effects of early protein malnutrition and repeated testing upon locomotor and exploratory behaviors in the elevated plus-maze.

Authors:  S S Almeida; R A Garcia; L M de Oliveira
Journal:  Physiol Behav       Date:  1993-10

2.  The use of a plus-maze to measure anxiety in the mouse.

Authors:  R G Lister
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

3.  "One-trial tolerance" to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state?

Authors:  S E File; H Zangrossi
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

4.  Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat.

Authors:  S Pellow; P Chopin; S E File; M Briley
Journal:  J Neurosci Methods       Date:  1985-08       Impact factor: 2.390

5.  Utility of an elevated plus-maze for the evaluation of memory in mice: effects of nootropics, scopolamine and electroconvulsive shock.

Authors:  J Itoh; T Nabeshima; T Kameyama
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

6.  Effect of various training procedures on performance in an elevated plus-maze: possible relation with brain regional levels of benzodiazepine-like molecules.

Authors:  C Da Cunha; M L De Stein; C Wolfman; R Koya; I Izquierdo; J H Medina
Journal:  Pharmacol Biochem Behav       Date:  1992-11       Impact factor: 3.533

7.  Actions and some interactions of 5-HT1A ligands in the elevated X-maze and effects of dorsal raphe lesions.

Authors:  M A Critchley; K Njung'e; S L Handley
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

8.  The effects of 5-HT1B characterizing agents in the mouse elevated plus-maze.

Authors:  D Benjamin; H Lal; L R Meyerson
Journal:  Life Sci       Date:  1990       Impact factor: 5.037

9.  A theory of benzodiazepine dependence that can explain whether flumazenil will enhance or reverse the phenomena.

Authors:  S E File; P K Hitchcott
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

10.  Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat.

Authors:  S Pellow; S E File
Journal:  Pharmacol Biochem Behav       Date:  1986-03       Impact factor: 3.533

View more
  38 in total

1.  Altered stress-induced anxiety in adenylyl cyclase type VIII-deficient mice.

Authors:  M L Schaefer; S T Wong; D F Wozniak; L M Muglia; J A Liauw; M Zhuo; A Nardi; R E Hartman; S K Vogt; C E Luedke; D R Storm; L J Muglia
Journal:  J Neurosci       Date:  2000-07-01       Impact factor: 6.167

2.  Measuring anxiety- and locomotion-related behaviours in mice: a new way of using old tests.

Authors:  Leanne M Fraser; Richard E Brown; Ahmed Hussin; Mara Fontana; Ashley Whittaker; Timothy P O'Leary; Lauren Lederle; Andrew Holmes; André Ramos
Journal:  Psychopharmacology (Berl)       Date:  2010-05-08       Impact factor: 4.530

3.  Anxiolytic-like effects of NMDA/glycine-B receptor ligands are abolished during the elevated plus-maze trial 2 in rats.

Authors:  Leandro J Bertoglio; Antonio P Carobrez
Journal:  Psychopharmacology (Berl)       Date:  2003-09-10       Impact factor: 4.530

4.  Cellular correlates of anxiety in CA1 hippocampal pyramidal cells of 5-HT1A receptor knockout mice.

Authors:  Emily Freeman-Daniels; Sheryl G Beck; Lynn G Kirby
Journal:  Psychopharmacology (Berl)       Date:  2010-10-28       Impact factor: 4.530

5.  Increased Metabotropic Glutamate Receptor 5 Signaling Underlies Obsessive-Compulsive Disorder-like Behavioral and Striatal Circuit Abnormalities in Mice.

Authors:  Kristen K Ade; Yehong Wan; Harold C Hamann; Justin K O'Hare; Weirui Guo; Anna Quian; Sunil Kumar; Srishti Bhagat; Ramona M Rodriguiz; William C Wetsel; P Jeffrey Conn; Kafui Dzirasa; Kimberly M Huber; Nicole Calakos
Journal:  Biol Psychiatry       Date:  2016-05-13       Impact factor: 13.382

6.  Free versus forced exposure to an elevated plus-maze: evidence for new behavioral interpretations during test and retest.

Authors:  Vincent Roy; Pierre Chapillon; Mustapha Jeljeli; Jean Caston; Catherine Belzung
Journal:  Psychopharmacology (Berl)       Date:  2008-11-08       Impact factor: 4.530

7.  A five minute experience in the elevated plus-maze alters the state of the benzodiazepine receptor in the dorsal raphe nucleus.

Authors:  L E Gonzalez; S E File
Journal:  J Neurosci       Date:  1997-02-15       Impact factor: 6.167

8.  Orexin neuropeptides contribute to the development and persistence of generalized avoidance behavior in the rat.

Authors:  Daniele Viviani; Patrizia Haegler; Francois Jenck; Michel A Steiner
Journal:  Psychopharmacology (Berl)       Date:  2014-10-16       Impact factor: 4.530

9.  Cerebral tryptophan hydroxylase activity, and 5-HT1A receptor, 5-HT2A receptor, and 5-HT transporter binding in grouped and isolated Roman RHA and RLA rats: relationships with behaviours in two models of anxiety.

Authors:  A Kulikov; N Castanon; P Mormède; F Chaouloff
Journal:  Psychopharmacology (Berl)       Date:  1995-10       Impact factor: 4.530

10.  Early-onset Parkinsonian behaviors in female Pink1-/- rats.

Authors:  Julia M Marquis; Samantha E Lettenberger; Cynthia A Kelm-Nelson
Journal:  Behav Brain Res       Date:  2019-09-19       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.